Marion R. Foote - Dec 16, 2022 Form 4 Insider Report for KINETA, INC./DE (KA)

Role
Director
Signature
/s/ Pauline Kenny, as Attorney-in-Fact
Stock symbol
KA
Transactions as of
Dec 16, 2022
Transactions value $
$250,000
Form type
4
Date filed
12/20/2022, 07:56 PM
Previous filing
Oct 19, 2022
Next filing
Apr 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KA Common Stock Award +112K 112K Dec 16, 2022 Direct F1
transaction KA Common Stock Award +656 +0.58% 113K Dec 16, 2022 Direct F2, F3
transaction KA Common Stock Award +3.44K +3.05% 116K Dec 16, 2022 Direct F4, F5
transaction KA Common Stock Award +860 +0.74% 117K Dec 16, 2022 Direct F6, F7
transaction KA Common Stock Award $250K +21.6K +18.48% $11.55* 139K Dec 16, 2022 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award +10.3K 10.3K Dec 16, 2022 Common Stock 10.3K $23.25 Direct F9, F10
transaction KA Stock Option (Right to Buy) Award +6.19K 6.19K Dec 16, 2022 Common Stock 6.19K $29.06 Direct F11, F12
transaction KA Stock Option (Right to Buy) Award +3.44K 3.44K Dec 16, 2022 Common Stock 3.44K $26.16 Direct F13, F14
transaction KA Warrants (Right to Buy) Award +6.19K 6.19K Dec 16, 2022 Common Stock 6.19K $21.80 Direct F15, F16
transaction KA Warrants (Right to Buy) Award +4.3K 4.3K Dec 16, 2022 Common Stock 4.3K $0.14 Direct F15, F17
transaction KA Warrants (Right to Buy) Award +401 401 Dec 16, 2022 Common Stock 401 $0.14 Direct F15, F18
transaction KA Warrants (Right to Buy) Award +4.44K 4.44K Dec 16, 2022 Common Stock 4.44K $0.14 Direct F15, F19
transaction KA Warrants (Right to Buy) Award +3.46K 3.46K Dec 16, 2022 Common Stock 3.46K $0.14 Direct F15, F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in connection with the Issuer's merger (the "Merger") with Kineta, Inc. ("Legacy Kineta") in accordance with the terms of the Agreement and Plan of Merger dated as of June 5, 2022, as amended on December 5, 2022 (the "Merger Agreement"), by and among the Issuer (f/k/a Yumanity Therapeutics, Inc.), Yacht Merger Sub, Inc. and Legacy Kineta. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Kineta common stock was entitled to receive 0.0688 shares of Common Stock. The Merger closed on December 16, 2022.
F2 Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on June 14, 2023, subject to the continuing service of the Reporting Person on such vesting date.
F3 Received in connection with the Merger in exchange for 9,545 shares of common stock underlying a Legacy Kineta RSU.
F4 Represents shares of Common Stock underlying a time-based RSU. The RSU will vest in full on June 14, 2023, subject to the continuing service of the Reporting Person on such vesting date.
F5 Received in connection with the Merger in exchange for 50,000 shares of common stock underlying a Legacy Kineta RSU.
F6 Represents shares of Common Stock underlying a time-based RSU. The RSU will vest in full on March 16, 2023, subject to the continuing service of the Reporting Person on such vesting date.
F7 Received in connection with the Merger in exchange for 12,500 shares of common stock underlying a Legacy Kineta RSU.
F8 Represents shares of Common Stock acquired by the Reporting Person immediately following the Merger in a private placement pursuant to a Securities Purchase Agreement dated as of June 5, 2022 and as amended on October 24, 2022 and December 5, 2022. The issuance of the shares to the Reporting Person was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
F9 The stock option is fully vested and exercisable.
F10 Received in connection with the Merger in exchange for options to acquire 150,000 shares of Legacy Kineta common stock for $1.60 per share.
F11 The stock option vested as to 1/3 of the total number of shares on February 10, 2021, an additional 1/3 of the total number of shares vested on February 10, 2022, and the remaining 1/3 of the total number of shares will vest on February 10, 2023, subject to the continuing service of the Reporting Person on each vesting date.
F12 Received in connection with the Merger in exchange for options to acquire 90,000 shares of Legacy Kineta common stock for $2.00 per share.
F13 The stock option vested as to 1/3 of the total number of shares on May 28, 2021, an additional 1/3 of the total number of shares vested on May 28, 2022, and the remaining 1/3 of the total number of shares will vest on February 10, 2023, subject to the continuing service of the Reporting Person on each vesting date.
F14 Received in connection with the Merger in exchange for options to acquire 50,000 shares of Legacy Kineta common stock for $1.80 per share.
F15 The warrants are immediately exercisable in full.
F16 Received in connection with the Merger in exchange for warrants to acquire 90,000 shares of Legacy Kineta common stock for $1.50 per share.
F17 Received in connection with the Merger in exchange for warrants to acquire 62,500 shares of Legacy Kineta common stock for $0.01 per share.
F18 Received in connection with the Merger in exchange for warrants to acquire 5,833 shares of Legacy Kineta common stock for $0.01 per share.
F19 Received in connection with the Merger in exchange for warrants to acquire 64,583 shares of Legacy Kineta common stock for $0.01 per share.
F20 Received in connection with the Merger in exchange for warrants to acquire 50,251 shares of Legacy Kineta common stock for $0.01 per share.